Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAUNORUBICIN vs ETOPOSIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAUNORUBICIN vs ETOPOSIDE: Safety Overview

Metric DAUNORUBICIN ETOPOSIDE
Total FAERS Reports 9,852 52,603
Deaths Reported 2,263 11,780
Death Rate 23.0% 22.4%
Hospitalizations 4,248 17,699
Average Patient Age 28.7 yrs 42.5 yrs
% Female Patients 46.4% 41.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Aug 30, 1995
Manufacturer Hikma Pharmaceuticals USA Inc. Avyxa Pharma, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued